⏱ GENERATED 12/15/2025
This report was generated once, at the time listed.
▼ NO MICRO CONTRACTS
Contracts or transactions under $2,000 are not included.
🚫 NOT OFFICIAL
Meter uses government data, but isn't an official source.
The vendors that received the most money from Office of Assistant Secretary for Preparedness and Response in October 2025, across all contracts awarded that month.
The most-awarded NAICS codes from Office of Assistant Secretary for Preparedness and Response in October 2025, across all awarded contracts.
Important phrases and terms that appear significantly more in Office of Assistant Secretary for Preparedness and Response contracts during October 2025 compared to government-wide patterns.
The highest-value individual contract awards from Office of Assistant Secretary for Preparedness and Response in October 2025.
$0
CAMBRIDGE, MASSACHUSETTS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | 541715
HEALTH R&D SERVICES; HEALTH CARE - OTHER; R&D ADMINISTRATIVE EXPENSES | AN44
THIS SYSTEM WOULD BE USED AND INTEGRATED WITHIN ROUTINE CARE FOR BURNS AND TRAUMATIC INJURIES, BUT WOULD ALSO HAVE THE POTENTIAL TO BE OF USE IN DETECTION VIRAL PNEUMONIA OF COVID 19 CASES.
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 24, 2025
5/8/20 → 12/31/26
$0
NEW YORK, NEW YORK
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | AN42
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE;0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 29, 2025
9/30/21 → 11/30/27
$0
DURHAM, NORTH CAROLINA
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | 541715
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | AN11
INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 22, 2025
9/27/22 → 9/26/26
$0
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
MEMED DIAGNOSTICS- THE R&D EFFORT TO DEMONSTRATE CLINICAL UTILITY OF MEMED BV, RAPID HOST-BASED DIAGNOSTIC (HBD) FOR DISTINGUISHING BACTERIAL VS VIRAL INFECTION
MEMED DIAGNOSTICS - DEMONSTRATE CLINICAL UTILITY OF MEMED BV, RAPID HBD FOR DISTINGUISHING BACTERIAL
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 31, 2025
9/22/23 → 10/31/26
$0
BETHESDA, MARYLAND
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | AN11
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 28, 2025
8/22/23 → 8/21/28
$0
BALTIMORE, MARYLAND
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP]).
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 9, 2025
9/29/23 → 9/16/26
$0
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
THRIXEN - RAPID AND MULTIPLEX POINT-OF-CARE TEST FOR EBOLA AND MALARIA DIAGNOSTICS (THRIXEN)
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Oct 23, 2025
9/23/24 → 4/30/26
$0
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
MACH32- DEVELOPMENT OF INTRAMUSCULAR TRANEXAMIC ACID FORMULATION
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Oct 9, 2025
9/27/24 → 3/31/26
$0
SUMMERVILLE, SOUTH CAROLINA
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 325414
HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | AN42
OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM
BIOPHARMACEUTICAL MANUFACTURING PREPAREDNESS CONSORTIUM (BIOMAP-CONSORTIUM)
OFC ASST SEC FOR PREPARENESS RES
31.0: Equipment
0001: DIRECT PROGRAM ACTIVITY
Oct 29, 2025
12/12/23 → 9/30/26
$0
SUMMERVILLE, SOUTH CAROLINA
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 325414
HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | AN42
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
OFC ASST SEC FOR PREPARENESS RES
31.0: Equipment
0001: DIRECT PROGRAM ACTIVITY;0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 22, 2025
1/12/24 → 12/31/26
The largest contract de-obligations (spending reductions or cancellations) from Office of Assistant Secretary for Preparedness and Response in October 2025.
-$13,614,795
HOLLY SPRINGS, NORTH CAROLINA
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES | AN14
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services;26.0: Supplies and materials
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 9, 2025
9/21/21 → 1/31/27
-$3,140,656
SWIFTWATER, PENNSYLVANIA
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | AN12
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED
BARDA - ASPR / DAAPPO / BARDA DCMA
26.0: Supplies and materials
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 24, 2025
7/27/23 → 12/31/25
-$873,794
DURHAM, NORTH CAROLINA
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES | AN14
THE OVERALL OBJECTIVE OF THIS SOW IS TO CREATE A PARTNERSHIP BETWEEN THE AGREEMENT RECIPIENT, DUKE UNIVERSITY ON BEHALF OF DUKE CLINICAL RESEARCH INSTITUTE (DCRI), AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO ENHANCE INNOVATI
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Oct 9, 2025
9/29/24 → 9/28/29
-$483,488
CAMBRIDGE, MASSACHUSETTS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
RED QUEEN THERAPEUTICS, INC - AOI#25(FASTX) R&D FOR RAPID RESPONSE PLATFORM FOR THE DEVELOPMENT OF A PAN-INFLUENZA VIRUS FUSION INHIBITOR FOR THE TREATMENT OF INFLUENZA VIRUS INFECTIONS
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Oct 29, 2025
5/10/24 → 7/9/25
-$372,754
SAN JOSE, CALIFORNIA
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
RESEARCH AND DEVELOPMENT- AOI #19 FOR THE DEVELOPMENT OF A BREAKTHROUGH NANOFLUID BREATHING AID FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS.
OFC ASST SEC FOR PREPARENESS RES
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Oct 8, 2025
6/29/23 → 10/7/25
The top locations where contract work for Office of Assistant Secretary for Preparedness and Response in October 2025 is performed.
4 contracts
2 contracts
1 contracts
6 contracts
1 contracts
3 contracts
1 contracts
1 contracts
2 contracts
1 contracts
4 contracts
1 contracts
1 contracts
6 contracts
2 contracts
1 contracts
2 contracts
1 contracts
1 contracts
2 contracts
The top locations where vendors receiving awards from Office of Assistant Secretary for Preparedness and Response in October 2025 list as their primary business address.
2 contracts
1 contracts
1 contracts
7 contracts
1 contracts
1 contracts
1 contracts
1 contracts
1 contracts
1 contracts
The congressional districts where contract work for Office of Assistant Secretary for Preparedness and Response in October 2025 will be performed.